Implementation of the EUCAST rapid antimicrobial susceptibility test (RAST) for carbapenemase/ESBL-producing Escherichia coli and Klebsiella pneumoniae isolates, and its effect on mortality.

MLA

Tayşi, Muhammet Rıdvan, et al. “Implementation of the EUCAST Rapid Antimicrobial Susceptibility Test (RAST) for Carbapenemase/ESBL-Producing Escherichia Coli and Klebsiella Pneumoniae Isolates, and Its Effect on Mortality.” Journal of Antimicrobial Chemotherapy (JAC), vol. 79, no. 7, July 2024, pp. 1540–46. EBSCOhost, https://doi.org/10.1093/jac/dkae125.

APA

Tayşi, M. R., Öcal, D., Şentürk, G. Ç., Çalişkan, E., Çelik, B., & Şencan, İ. (2024). Implementation of the EUCAST rapid antimicrobial susceptibility test (RAST) for carbapenemase/ESBL-producing Escherichia coli and Klebsiella pneumoniae isolates, and its effect on mortality. Journal of Antimicrobial Chemotherapy (JAC), 79(7), 1540–1546. https://doi.org/10.1093/jac/dkae125

Chicago

Tayşi, Muhammet Rıdvan, Duygu Öcal, Gönül Çiçek Şentürk, Elif Çalişkan, Bahar Çelik, and İrfan Şencan. 2024. “Implementation of the EUCAST Rapid Antimicrobial Susceptibility Test (RAST) for Carbapenemase/ESBL-Producing Escherichia Coli and Klebsiella Pneumoniae Isolates, and Its Effect on Mortality.” Journal of Antimicrobial Chemotherapy (JAC) 79 (7): 1540–46. doi:10.1093/jac/dkae125.